Kidney tubular toxicity of maintenance pemetrexed therapy

American Journal of Kidney Diseases

Volumn 58, Issue 5, 2011, Pages 817-820

  Glezerman, Ilya G ^a   Pietanza, M Catherine ^a   Miller, Vincent ^a   Seshan, Surya V ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Nephrotoxicity; pemetrexed; tubulointerstitial injury

Indexed keywords

AMLODIPINE; BEVACIZUMAB; CARBOPLATIN; CREATININE; DIURETIC AGENT; FOLIC ACID; GLIBENCLAMIDE; HEMOGLOBIN; IRON; LISINOPRIL; LOSARTAN; METFORMIN; PACLITAXEL; PEMETREXED; QUINAPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURGERY; CASE REPORT; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GLUCOSURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TUBULAR TOXICITY; KIDNEY TUBULE DAMAGE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; URINALYSIS;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; GLUTAMATES; GUANINE; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MIDDLE AGED;

EID: 80055009917     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.04.030     Document Type: Article

References (16)

1. A.A. Adjei Pharmacology and mechanism of action of pemetrexed Clin Lung Cancer 5 suppl 2 2004 S51 S55
2. L.R. Villela, B.L. Stanford, and S.R. Shah Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy Pharmacotherapy 26 2006 641 654 (Pubitemid 43673047)
3. A.C. Mita, C.J. Sweeney, and S.D. Baker Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function [see comment] J Clin Oncol 24 2006 552 562 (Pubitemid 46630417)
4. D.A. Rinaldi, J.G. Kuhn, and H.A. Burris A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation Cancer Chemother Pharmacol 44 1999 372 380 (Pubitemid 29455582)
5. V. Vootukuru, Y.P. Liew, and J.V. Nally Jr Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer Med Oncol 23 2006 419 422 (Pubitemid 44507152)
6. J. Michels, J.P. Spano, I. Brocheriou, G. Deray, D. Khayat, and H. Izzdine Acute tubular necrosis and interstitial nephritits during pemetrexed therapy Case Rep Oncol 2 2009 53 56
7. A. Stavroulopoulos, L. Nakopoulou, A.M. Xydakis, V. Aresti, A. Nikolakopoulou, and G. Klouvas Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed Ren Fail 32 2010 1000 1004
8. V. Eremina, J.A. Jefferson, and J. Kowalewska VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136 (Pubitemid 351398487)
9. M.A. Perazella Renal vulnerability to drug toxicity Clin J Am Soc Nephrol 4 2009 1275 1283
10. 12 and folate homeostasis: characterization of receptors for tubular uptake of vitamins and carrier proteins Am J Physiol Renal Physiol 291 2006 F22 F36
11. Y.G. Assaraf The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis Drug Resist Updat 9 2006 227 246 (Pubitemid 44750843)
12. D.L. Alison, D.R. Newell, and C. Sessa The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) Cancer Chemother Pharmacol 14 1985 265 271 (Pubitemid 15118653)
13. V.L. Damaraju, K.F. Hamilton, M.L. Seth-Smith, C.E. Cass, and M.B. Sawyer Characterization of binding of folates and antifolates to brush-border membrane vesicles isolated from human kidney Mol Pharmacol 67 2005 453 459 (Pubitemid 40216738)
14. T. Ciuleanu, T. Brodowicz, and C. Zielinski Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Lancet 374 2009 1432 1440
15. D.P. van den Bogaert, E.M. Pouw, and G. van Wijhe Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma J Thorac Oncol 1 2006 25 30 (Pubitemid 47164017)
16. C. Manegold, G. Schmid-Bindert, and L.R. Pilz Pemetrexed for the treatment of non-small-cell lung cancer Expert Rev Anticancer Ther 9 2009 1195 1209